OOIR: Observatory of International Research

Papers

(The TQCC of Clinics in Liver Disease is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Chronic Hepatitis B Virus in Patients with Chronic Hepatitis C Virus	254
Contributors	36
Contributors	34
Forthcoming Issues	34
Forthcoming Issues	28
Copyright	27
Forthcoming Issues	23
Navigating the Management of Hepatocellular Carcinoma	23
Forthcoming Issues	21
Hepatitis B and Health Care Workers	21
Endoscopic Ultrasound-Guided Liver Biopsy	19
The Role of Liver Transplantation in Hepatocellular Carcinoma	19
Artificial Intelligence, Large Language Models, and Digital Health in the Management of Alcohol-Associated Liver Disease	18
Contributors	18
Controversies in the Management of Hepatitis B	17
The Changing Demographics of Hepatitis B Virus Infection	15
Recurrent and De Novo Liver Disease After Liver Transplantation	15
Through the Scope Hepatobiliary Interventions in Patients with Liver Diseases: Minimizing Risks and Improving Outcomes	15
Forthcoming Issues	15
Contents	14
Overview of New Targets for Hepatitis B Virus	14
Advances in Viral Hepatitis B and D: Moving Toward the Goals of Elimination	14
Pathogenesis of Alcohol-Associated Liver Disease	13
Assessing the Severity and Prognosis of Alcoholic Hepatitis	13
Controversies in Treating Chronic HBV	13

Preface	12
Clinical Vignettes Illustrating the Spectrum of Hepatocellular Carcinoma Presentation and Treatment	12
What is the Path Forward to Treat Hepatitis Delta Virus?	11
Management of Biliary Complications in Liver Transplant Recipients	11
Preface	10
Primary Biliary Cholangitis	10
Consultations in Liver Disease	10
Contents	9
The Use of Hepatitis C Virus–Positive Organs in Hepatitis C Virus–Negative Recipients	9
Evaluation and Management of Pruritus in Primary Biliary Cholangitis	9
Nonalcoholic Fatty Liver Disease in Latin America and Australia	9
Alcohol-Associated Liver Disease	8
Substance Use Disorders and Interprofessional Management in the Pre and Post Liver Transplant Settings	8
Targeting Hepatitis B Virus DNA Using Designer Gene Editors	8
Primary Sclerosing Cholangitis	8
Portal Hypertension and its Complications	8
Contributors	8
Minimal Hepatic Encephalopathy	8
Hepatocellular Carcinoma	7
Pathogenetic Pathways in Nonalcoholic Fatty Liver Disease	7
Hepatorenal Syndrome	7
Beyond the Liver	7
Emerging Pharmacologic Treatments for Alcohol-Associated Hepatitis	7
Noninvasive Fibrosis Testing in Chronic Liver Disease Including Caveats	7
Copyright	7
Role of Endoscopic Retrograde Cholangiopancreatography in the Diagnosis and Management of Cholestatic Liver Diseases	7
Biliary Atresia in Children	7
Prognostic Scoring Systems in Primary Biliary Cholangitis	7
Pharmacologic Management of Hepatic Encephalopathy	7
Improving Diagnostic Yield in Indeterminate Biliary Strictures	6
Emerging Therapies for Alcoholic Hepatitis	6
Copyright	6
Forthcoming Issues	6
Navigating Hepatocellular Carcinoma	6
The Liver in Diabetes and Metabolic Syndrome	6
Controversies in Treating Chronic Hepatitis B virus	6
Hepatitis B and C in Children	6
Contents	6
Preventing Readmissions for Hepatic Encephalopathy	6
Treatment of Primary Sclerosing Cholangitis Including Transplantation	6
The Liver in Hematologic Malignancies	6
Novel Therapies in Primary Biliary Cholangitis	6
The Interplay Between Nonalcoholic Fatty Liver Disease and Kidney Disease	6
Preface	6
Use of Hepatitis B Virus–Positive Organs in Organ Transplantation	6
Hepatic Encephalopathy	5
Genetics of Primary Biliary Cholangitis	5
Current Trends in Liver Transplantation for Alcoholic Hepatitis	5
Chronic Hepatitis B	5
Forthcoming Issues	5

Renal Insufficiency in Patients with Cirrhosis	5
Noninvasive Evaluation of Fibrosis and Portal Hypertension in Primary Biliary Cholangitis	5
The Evolving Role of Therapeutic Endoscopy in Patients with Chronic Liver Diseases	5
Overview of Progressive Familial Intrahepatic Cholestasis	5
Kidney Allocation Issues in Liver Transplantation Candidates with Chronic Kidney Disease and Severe Kidney Liver Injury	5
Amyloidosis and the Liver	5
What Is the Real Epidemiology of Hepatitis D Virus and Why so Many Mixed Messages?	5
Primary Biliary Cholangitis	5
Portal Hypertension and its Complications: A Guided Tour of the Post–Baveno 7 Landscape	5